Search

Your search keyword '"Naas, Thierry"' showing total 1,140 results

Search Constraints

Start Over You searched for: Author "Naas, Thierry" Remove constraint Author: "Naas, Thierry" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,140 results on '"Naas, Thierry"'

Search Results

1. IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022

3. Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France

4. Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study

5. Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

8. Polyclonal Dissemination of OXA-232 Carbapenemase--Producing Klebsiella pneumoniae, France, 2013-2021

11. Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection

16. Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181.

17. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

19. Multicenter study to assess the use of BL-DetecTool for the detection of CTX-M-type ESBLs and carbapenemases directly from clinical specimens

22. An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens

26. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)

27. Emergence and Polyclonal Dissemination of OXA-244--Producing Escherichia coli, France

28. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

30. A multicentre evaluation of the NG-test DetecTool OXA-23 for the rapid detection of OXA-23 carbapenemase directly from blood cultures.

32. Multidrug-Resistant Pathogens Contaminate River Water Used in Irrigation in Disenfranchised Communities

33. The emergence of carbapenemase-producing Enterobacterales in hospitals: a major challenge for a debilitated healthcare system in Lebanon

35. Emergence and rapid dissemination of highly resistant NDM-14-producing Klebsiella pneumoniae ST147, France, 2022

40. Emergence of New Non-Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Isolates, France

41. Genomic characterization of plasmid-borne colistin resistance variants, mcr-1.1 and mcr-1.26, in multidrug-resistant Escherichia coli isolated from backyard farm animals

42. Emergence of blaNDM-5-harbouring Escherichia coli ST617 in refugee and host communities and their environment.

44. Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9

48. Clinical bacteriology in low-resource settings: today's solutions

50. Meat and Fish as Sources of Extended-Spectrum [beta]-Lactamase-Producing Escherichia coli, Cambodia

Catalog

Books, media, physical & digital resources